GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annexin Pharmaceuticals AB (OSTO:ANNX) » Definitions » Balance Sheet Cash And Cash Equivalents

Annexin Pharmaceuticals AB (OSTO:ANNX) Balance Sheet Cash And Cash Equivalents


View and export this data going back to 2017. Start your Free Trial

What is Annexin Pharmaceuticals AB Balance Sheet Cash And Cash Equivalents?

Please go to this page to see Cash And Cash Equivalents for non-financial companies.


Annexin Pharmaceuticals AB Business Description

Industry
Traded in Other Exchanges
N/A
Address
Norrtullsgatan 6, Stockholm, SWE, SE-113 29
Annexin Pharmaceuticals AB is a biotechnology company. It is developing biological drug candidate ANXV, a recombinant human protein Annexin A5 for treatment of various cardiovascular diseases. The company also focuses on development of ANXV for the treatment of retinal vein occlusion.